<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        38-762-12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2012
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RINGERS SOLUTION FOR I.V. INFUSION IN VIAFLEX
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SODIUM CHLORIDE,POTASSIUM CHLORIDE, CALCIUM CHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        8.6,0.3,0.33
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        g/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        5.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BAXTER CO LIMITED" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BAXTER CO LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 613]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            BAXTER CO LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Baxter Company Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05BB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:5.25pt; margin-right:0in">Ringer&rsquo;s Solution for Infusion is a solution of the following substances in water:</p><p style="margin-left:22.2pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->sodium chloride</p><p style="margin-left:22.2pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->potassium chloride</p><p style="margin-left:22.2pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->calcium chloride dihydrate</p><p style="margin-left:5.25pt; margin-right:5.55pt">Ringer&rsquo;s Solution for Infusion is used to treat a loss of body water (dehydration) and chemicals (e.g. by heavy sweating, kidney disorders)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:5.25pt"><strong>Do</strong><strong> </strong><strong>NOT</strong><strong> </strong><strong>receive</strong><strong> </strong><strong>Ringer&rsquo;s Solution</strong><strong> </strong><strong>for</strong><strong> </strong><strong>Infusion</strong><strong> </strong><strong>if</strong><strong> </strong><strong>you are suffering from any of the following conditions</strong></p><p style="margin-left:22.2pt; margin-right:31.4pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Preterm newborn infants and term newborn infants (&le;28 days of age): Your child must not receive a certain antibiotic called ceftriaxone as a drip into a vein at the same time with this medicine</p><p style="margin-left:22.2pt; margin-right:0in; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->when there is too much fluid in the spaces around the cells of the body (extracellular hyperhydration)</p><p style="margin-left:22.2pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->when there is a larger volume of blood in the blood vessels than there should be (hypervolaemia)</p><p style="margin-left:22.2pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->severe kidney failure (when your kidneys do not work well and you require dialysis)</p><p style="margin-left:22.2pt; margin-right:5.55pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->uncompensated heart failure. This is heart failure that is not adequately treated and causes symptoms such as:</p><p style="margin-left:39.1pt; margin-right:0in; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->shortness of breath</p><p style="margin-left:39.1pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->swelling of the ankles</p><p style="margin-left:22.15pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->when there is too much fluid in the body caused by too many salts in the blood (hypertonic dehydration)</p><p style="margin-left:22.15pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->higher levels of potassium in the blood than normal (hyperkalaemia)</p><p style="margin-left:22.15pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->higher levels of sodium in the blood than normal (hypernatraemia)</p><p style="margin-left:22.15pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->higher levels of calcium in the blood than normal (hypercalcaemia)</p><p style="margin-left:22.15pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->higher levels of chloride in the blood than normal (hyperchloraemia)</p><p style="margin-left:22.15pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->severe high blood pressure (hypertension)</p><p style="margin-left:22.15pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->build up of fluid under the skin, affecting all parts of the body (general oedema)</p><p style="margin-left:22.15pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis)</p><p style="margin-left:22.1pt; margin-right:20.1pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->if you are taking cardiac glycosides (cardiotonics) used to treat heart failure, such as digitalis or digoxin. (see also &ldquo;Other Medicines and Ringer&rsquo;s Solution for Infusion&rdquo;)</p><p><strong>Warnings and precautions</strong></p><p style="margin-left:5.2pt; margin-right:0in">Talk to your doctor or nurse if you have or have had any of the following medical conditions:</p><p style="margin-right:13.8pt; text-align:justify; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->In patients of any age a certain antibiotic named ceftriaxone must not be mixed or given at the same time with any calcium containing solutions given to you by a drip into your vein. Your doctor knows this and will not give you them together even via different infusion lines or different infusion sites.</p><p style="margin-left:22.1pt; margin-right:20.1pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->However, in patients older than 28 days your doctor may give calcium and ceftriaxone sequentially one after the other if infusion lines at different sites are used or if the infusion lines are replaced or were thoroughly flushed with physiological salt solution between the infusions to avoid precipitation. If you or your child suffer from low blood volume your doctor will avoid giving you or your child calcium and ceftriaxone sequentially.</p><ul><li><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->heart failure</li><li><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->respiratory failure (lung disease) (special monitoring may be required in the above conditions)</li><li><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->any type of heart disease or impaired heart function</li><li><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->impaired kidney function</li><li><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->high blood pressure (hypertension)</li><li><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->build up of fluid under the skin, particularly around the ankles (peripheral oedema)</li><li><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->build up of fluid in the lungs (pulmonary oedema)</li><li><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->high blood pressure during pregnancy (pre-eclampsia)</li><li><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->a disease that causes high levels of a hormone called aldosterone (aldosteronism)</li></ul><p style="margin-right:20.1pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->any other condition associated with sodium retention (when the body retains too much sodium), such as treatment with steroids (see also&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; below &ldquo;Other medicines and Ringer&rsquo;s Solution for Infusion&rdquo;).</p><p style="margin-left:22.1pt; margin-right:55.2pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp; <!--[endif]-->adrenocortical insufficiency (this disease of the adrenal gland affects hormones that control the concentration of chemicals in the body).</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->a loss of water from the body (acute dehydration, e.g. from vomiting or diarrhoea)</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->extensive tissue damage (as can occur in severe burns)</p><p style="margin-left:22.05pt; margin-right:11.45pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->diseases associated with high levels of vitamin D (e.g. sarcoidosis, a disease affecting the skin and internal organs)</p><p style="margin-left:5.15pt; margin-right:0in">When you are given this infusion, your doctor will take blood and urine samples and monitor:</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the amount of fluid in your body</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->your vital signs</p><p style="margin-left:22.05pt; margin-right:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the amount of chemicals such as sodium, potassium, calcium and chlorides in your blood (your plasma electrolytes)</p><p style="margin-left:5.15pt; margin-right:0in">Although Ringer&rsquo;s Solution for Infusion contains potassium and calcium, it does not contain enough to:</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->maintain levels of these chemicals</p><p style="margin-left:22.05pt; margin-right:11.45pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->treat very low blood plasma levels of potassium (severe potassium deficiency) or calcium (severe calcium deficiency).</p><p style="margin-left:5.1pt; margin-right:12.0pt">Once your dehydration has been treated using Ringer&rsquo;s Solution for Infusion, your doctor will give you a different infusion to provide you with enough potassium and calcium. Your doctor will take into account if you are receiving parenteral nutrition (nutrition given by infusion into a vein). If you are given Ringer&rsquo;s Solution &nbsp;&nbsp;for Infusion for a long time, you will be given an extra source of nutrients.</p><p style="margin-left:5.1pt; margin-right:11.45pt">Calcium chloride can be harmful if injected into the body tissues. Therefore, the Ringer&rsquo;s Solution for Infusion must not be given by injecting it into a muscle (intramuscular injection). Also, your doctor will make every effort to avoid the escape of the solution into the tissues surrounding the vein.</p><p style="margin-left:5.1pt; margin-right:20.1pt">Ringer&rsquo;s Solution for Infusion must not be given through the same needle as a blood transfusion. This can damage the red blood cells or cause them to clump together.</p><p><strong>Other medicines and Ringer&rsquo;s Solution for Infusion</strong></p><p style="margin-left:5.2pt; margin-right:104.25pt">Tell your doctor or nurse if you are taking or have recently taken any other medicines. It is particularly important that you inform your doctor if you are taking:</p><p style="margin-left:22.15pt; margin-right:0in; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ceftriaxone (an antibiotic), when given intravenously (see Warnings and precautions)</p><p style="margin-left:22.15pt; margin-right:14.1pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->cardiac glycosides (cardiotonics) such as digitalis or digoxin, used to treat heart failure as they must not be used with Ringer&rsquo;s Solution for Infusion (see also section &ldquo;Do not receive Ringer&rsquo;s Solution for Infusion if you are suffering from&hellip;&rdquo;). The effects of these drugs can be increased by calcium. This can lead to life threatening changes to the heart rhythm</p><p style="margin-left:22.15pt; margin-right:0in; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->corticosteroids (anti-inflammatory medicines)</p><p style="margin-left:5.2pt; margin-right:125.45pt; text-indent:0in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->carbenoxolone (an anti-inflammatory medicine used to treat stomach ulcers) These medicines can cause the body to accumulate sodium and water, leading to:</p><p style="margin-left:22.15pt; margin-right:0in; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->tissue swelling due to fluid collection under the skin (oedema)</p><p style="text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->high blood pressure (hypertension).</p><p style="margin-left:5.2pt; margin-right:14.1pt">The following medicines can increase the concentration of potassium in the blood. This effect can be life- threatening. A rise in the blood potassium levels is more likely to occur if you have kidney disease.</p><p style="margin-left:22.1pt; margin-right:55.75pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->potassium-sparing diuretics (certain water tablets, e.g. amiloride, spironolactone, triamterene) (Note that these medicines may be included in combination medicinal products)</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->angiotensin converting enzyme (ACE) inhibitors (used to treat high blood pressure)</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->angiotensin II receptor antagonists (used to treat high blood pressure)</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->tacrolimus (used to prevent rejection of a transplant and to treat some skin diseases)</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->cyclosporin (used to prevent rejection of a transplant)</p><p style="margin-left:5.15pt; margin-right:0in">Other medicines that can affect or be affected by Ringer&rsquo;s Solution for Infusion include:</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->thiazide diuretics such as hydrochlorothiazide or chlortalidone</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->vitamin D</p><p><strong>Ringer&rsquo;s Solution for Infusion with food and drink</strong></p><p style="margin-left:5.15pt; margin-right:0in">You should ask your doctor about what you can eat or drink.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p style="margin-left:5.15pt; margin-right:14.1pt">If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking this medicine.</p><p style="margin-left:5.15pt; margin-right:0in">Ringer&rsquo;s Solution for Infusion can be used safely during pregnancy or breast-feeding.</p><p style="margin-left:5.15pt; margin-right:14.1pt">Calcium can reach your unborn baby through the placenta and, after birth, through the breast milk. Your doctor will monitor the levels of chemicals in your blood and the amount of fluid in your body.</p><p style="margin-left:5.15pt; margin-right:14.1pt">However, if another medicine is to be added to your solution for infusion during pregnancy or breast-feeding you should:</p><p style="margin-left:22.05pt; margin-right:0in; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->consult your doctor</p><p style="margin-left:22.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->read the Package Leaflet of the medicine that is to be added.</p><p><strong>Driving and using machines</strong></p><p style="margin-left:5.1pt; margin-right:0in">Ringer&rsquo;s Solution for Infusion does not affect your ability to drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p style="margin-left:5.1pt; margin-right:0in">Ringer&rsquo;s Solution for Infusion will be given to you by a doctor or nurse. Your doctor will decide on how much you need and when it is to be given. This will depend on your age, weight, and condition and the reason for treatment. The amount you are given may also be affected by other treatments you are receiving.</p><p>You should NOT be given Ringer&rsquo;s Solution for Infusion if there are particles floating in the solution or if the pack is damaged in any way.</p><p style="margin-left:5.2pt; margin-right:14.1pt"><strong>&nbsp;</strong>Ringer&rsquo;s Solution for Infusion will usually be given to you through a plastic tube attached to a needle in a vein. Usually a vein in your arm is used to give you the infusion. However, your doctor may use another method to give you the medicine.</p><p style="margin-left:5.2pt; margin-right:0in">When you are given Ringer&rsquo;s Solution for Infusion, your doctor will perform blood tests to monitor your:</p><p style="text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->blood levels of sodium, potassium, calcium and chloride</p><p style="text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->your fluid levels</p><p style="margin-left:5.2pt; margin-right:14.1pt">Any unused solution should be thrown away. You should NOT be given an infusion of Ringer&rsquo;s Solution for Infusion from a bag that has been partly used.</p><p>If you receive more Ringer&rsquo;s Solution for Infusion than you should</p><p style="margin-left:5.2pt; margin-right:14.1pt"><strong>&nbsp;</strong>If you are given too much Ringer&rsquo;s Solution for Infusion (over-infusion), or you are given your infusion too quickly, this may lead to the following symptoms:</p><p style="text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->water and/or sodium (salt) overload with build up of liquid in the tissues (oedema) causing swelling</p><p style="text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->pins and needles in the arms and legs (paresthesia)</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->muscle weakness</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->an inability to move (paralysis)</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->an irregular heartbeat (cardiac arrhythmias)</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->heart block (a very slow heartbeat)</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->cardiac arrest (the heart stops beating; a life-threatening situation)</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->confusion</p><p style="text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->a decreased appetite (anorexia)</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->feeling sick (nausea)</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->vomiting</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->constipation</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->abdominal pain</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->mental disturbances such as irritability or depression</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->drinking lots of water (polydipsia)</p><p style="margin-left:22.05pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->producing more urine than normal (polyuria)</p><p style="margin-left:22.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->kidney disease due to build up of calcium in the kidneys (nephrocalcinosis)</p><p style="margin-left:22.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->kidney stones</p><p style="margin-left:22.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->coma (unconsciousness)</p><p style="margin-left:22.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->chalky taste</p><p style="margin-left:22.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->redness (hot flushes)</p><p style="margin-left:22.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->dilatation of the blood vessels in the skin (peripheral vasodilatation)</p><p style="margin-left:22.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->acidification of the blood (acidosis) leading to tiredness, confusion, lethargy and increased breathing rate</p><p style="margin-left:5.1pt; margin-right:14.1pt">If you develop any of these symptoms you must inform your doctor immediately. Your infusion will be stopped and you will be given treatment depending on the symptoms.</p><p style="margin-left:5.1pt; margin-right:5.55pt">If a medicine has been added to your Ringer&rsquo;s Solution for Infusion before over-infusion occurs, that medicine may also cause symptoms. You should read the Package Leaflet of the added medicine for a list of possible symptoms.</p><p>Stop receiving your Ringer&rsquo;s Solution for Infusion</p><p style="margin-left:5.15pt; margin-right:0in"><strong>&nbsp;</strong>Your doctor will decide when to stop giving you this infusion.</p><p style="margin-left:5.15pt; margin-right:0in">If you have any further questions on the use of this medicine, ask your doctor or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:10.2pt; margin-right:80.35pt">Like all medicines, this medicine can cause side effects, although not everybody gets them. The side effects are listed according to their frequencies.</p><p style="margin-left:10.2pt; margin-right:0in; text-align:justify"><strong>Very</strong><strong> </strong><strong>common</strong><strong> </strong>(occurring in more than 1 of every 10 patients)</p><p style="margin-left:10.2pt; margin-right:96.7pt; text-indent:0in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->changes in the concentrations of the chemicals in the blood (electrolyte disturbances) If you suffer from heart disease or fluid in the lungs (pulmonary oedema):</p><p style="margin-left:27.1pt; margin-right:0in; text-align:justify; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->too much fluid in the body (hyperhydration)</p><p style="margin-left:27.1pt; text-align:justify; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->heart failure</p><p>Other</p><p style="margin-left:27.1pt; margin-right:0in; text-align:justify; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->reactions due to the administration technique:</p><p style="margin-left:43.55pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->fever (febrile response)</p><p style="margin-left:43.55pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->infection at the site of infusion</p><p style="margin-left:43.55pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->local pain or reaction (redness or swelling at the site of infusion)</p><p style="margin-left:43.55pt; margin-right:21.55pt; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->irritation and inflammation of the vein into which the solution is infused (phlebitis). This can cause redness, pain or burning and swelling along the path of the vein into which the solution is infused.</p><p style="margin-left:43.55pt; margin-right:21.55pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the formation of a blood clot (venous thrombosis) at the site of infusion, which causes pain, swelling or redness in the area of the clot</p><p style="margin-left:43.55pt; margin-right:21.55pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->escape of the infusion solution into the tissues around the vein (extravasation). This can damage the tissues and cause scarring.</p><p style="margin-left:10.15pt; margin-right:0in; text-align:justify">If a medicine has been added to the solution for infusion, the added medicine may also cause side effects.</p><p style="margin-left:10.15pt">These side effects will depend on the medicine that has been added. You should read the Package Leaflet of the added medicine for a list of possible symptoms.</p><p style="margin-left:10.15pt; margin-right:21.55pt">If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet.</p><p>Reporting of side effects</p><p style="margin-left:10.15pt; margin-right:5.4pt; text-align:justify">If you get any side effect, talk to your doctor or nurse. This includes any possible side effect not listed in this leaflet. You can also report side effects directly via the national reporting system listed below. By reporting side effects, you can help provide more information on the safety of this medicine.</p><table cellspacing="1" cellpadding="0" border="1" style="width:375.0pt"><tbody><tr><td><p>&bull; Saudi Arabia:</p><p>- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull; Fax: +966-11-205-7662<br />&bull; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />&bull; Toll free phone: 8002490000<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: www.sfda.gov.sa/npc</p><p>&bull; Other GCC States:</p><p>- Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:10.2pt; margin-right:221.0pt; text-indent:0in"><!--[if !supportLists]--><strong>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><!--[endif]-->Keep this medicine out of the sight and reach of children.</p><p style="margin-left:10.2pt; margin-right:221.0pt; text-indent:0in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&deg;C..</p><p style="margin-left:10.2pt; margin-right:11.45pt; text-indent:53.25pt">Do not use this medicine after the expiry date which is stated on the bag. The expiry date refers to the last day of that month.</p><p style="margin-left:5.1pt; margin-right:0in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp; &nbsp; Do not use this medicine if you notice particles floating in the solution or if the unit is damaged in any way</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><!--[if !supportLists]-->1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->What Ringer&rsquo;s Solution for Infusion contains</p><p style="margin-left:10.2pt; margin-right:0in">The active substances are:</p><p style="margin-left:10.2pt; text-indent:16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->sodium chloride: 8.60 g per litre</p><p style="margin-left:44.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->potassium chloride: 0.30 g per litre</p><p style="margin-left:10.2pt; margin-right:244.95pt; text-indent:16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->calcium chloride dihydrate: 0.33 g per litre The other ingredients are:</p><p style="margin-left:44.05pt; margin-right:0in; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->water for injections</p><p style="margin-left:44.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->sodium hydroxide</p><p style="margin-left:44.05pt; text-indent:-16.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->hydrochloric Acid</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
Ringer’s Solution for Infusion is a clear solution, free from visible particles.
It is supplied in a poly(vinyl chloride) plastic bags (VIAFLEX ). Each bag is wrapped in a sealed, protective, outer plastic overpouch.

The bag sizes are:
-	500 ml
-	1000 ml

The bags are supplied in cartons. Each carton contains one of the following quantities:
-	26 bags of 500 ml
-	16 bags of 1000 ml

Not all pack sizes may be marketed

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:10.15pt; margin-right:292.3pt"><strong>Marketing Authorisation Holder :</strong></p><p style="margin-left:10.15pt; margin-right:0in">Baxter Company Limited</p><p style="margin-left:5.2pt; margin-right:292.3pt">2nd Industrial Zone Road no 2041 Dammam, Saudi Arabia</p><p style="margin-left:10.15pt; margin-right:0in"><strong>Manufacturers:</strong></p><p style="margin-left:10.15pt; margin-right:0in">Baxter Company Limited</p><p style="margin-left:5.2pt; margin-right:292.3pt">2nd Industrial Zone Road no 2041 Dammam, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                11/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL" style="margin-right:5.25pt; text-align:right">هو محلول للحقن يحتوي على المواد التالية في الماء:</p><p dir="RTL" style="margin-left:0in; margin-right:22.2pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كلوريد الصوديوم</p><p dir="RTL" style="margin-left:0in; margin-right:22.2pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كلوريد البوتاسيوم</p><p dir="RTL" style="margin-left:0in; margin-right:22.2pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ثنائي هيدرات كلوريد الكالسيوم</p><p dir="RTL" style="margin-right:5.25pt; text-align:right">يُستخدم محلول رينجر لمعالجة نقص المياه في الجسم (الجفاف) والمواد الكيميائية (على سبيل المثال عن طريق التعرّق الشديد، واضطرابات الكلى)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:0in; margin-right:5.25pt; text-align:right"><strong>لا تستخدم محلول رينجر إذا كنت تعاني أيّاً من الحالات التالية</strong></p><p dir="RTL" style="margin-left:31.4pt; margin-right:22.2pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الأطفال الخدّج وحديثو الولادة (أصغر من 28 يوماً): لا ينبغي أن يحصل طفلك على مضادٍ حيوي يُسمى سيفترياكسون عبر تنقيط بالوريد في الوقت ذاته مع هذا الدواء</p><p dir="RTL" style="margin-left:0in; margin-right:22.2pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->احتباس السوائل في المساحات التي تحيط بخلايا الجسم (فرط التعرّق خارج الخلية)</p><p dir="RTL" style="margin-left:0in; margin-right:22.2pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->زيادة حجم الدم في الأوعية الدموية عن المعدّل الطبيعي (فرط حجم الدم)</p><p dir="RTL" style="margin-left:0in; margin-right:22.2pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فشل حادّ في وظيفة الكلى (عندما لا تؤدي الكلية وظيفتها جيداً ويُصبح هناك حاجة لغسل الكلى)</p><p dir="RTL" style="margin-left:5.35pt; margin-right:22.2pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فَشل القلب الغير معوض، أي فشل القلب الذي لم يتم علاجه بشكلٍ كافٍ ويسبّب الأعراض مثل:</p><p dir="RTL" style="margin-left:0in; margin-right:39.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الضيق في التنفس</p><p dir="RTL" style="margin-left:0in; margin-right:39.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تورّم الكاحلين</p><p dir="RTL" style="margin-left:0in; margin-right:22.15pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->احتباس الكثير من السوائل في الجسم الناجم عن نسبة أملاح كبيرة في الدم (جفاف مفرط التوتر)</p><p dir="RTL" style="margin-left:0in; margin-right:22.15pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ارتفاع مستوى البوتاسيوم في الدم أعلى من المعدّل الطبيعي (فرط البوتاسيوم في الدم)</p><p dir="RTL" style="margin-left:0in; margin-right:22.15pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->عندما يكون مستوى الصوديوم في الدم أعلى من المعدّل الطبيعي (زيادة الصوديوم في الدم)</p><p dir="RTL" style="margin-left:0in; margin-right:22.15pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->عندما يكون مستوى الكالسيوم في الدم أعلى من المعدّل الطبيعي (فرط الكالسيوم في الدم)</p><p dir="RTL" style="margin-left:0in; margin-right:22.15pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->عندما يكون مستوى الكلوريد في الدم أعلى من المعدّل الطبيعي (زيادة الكلوريد في الدم)</p><p dir="RTL" style="margin-left:0in; margin-right:22.15pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ارتفاع حاد في ضغط الدم</p><p dir="RTL" style="margin-left:0in; margin-right:22.15pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->انتشار سائل تحت البشرة في جميع أنحاء الجسم (استسقاء عامّ)</p><p dir="RTL" style="margin-left:0in; margin-right:22.15pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->التليف الكبدي الاستسقائي الذي يُسبّب احتباس السوائل في البطن</p><p>&nbsp;</p><p dir="RTL" style="margin-left:14.5pt; margin-right:22.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->في حال تناول جليكوسيدات القلب (مقويات للقلب) المستخدمة لعلاج قصور القلب، مثل الديجيتال أو الديجوكسين. (راجع أيضاً &quot;تناول أدوية أخرى و محلول رينجر&quot;)</p><p><strong>تحذيرات واحتياطات</strong></p><p dir="RTL" style="margin-left:0in; margin-right:5.2pt; text-align:right">أعلم الطبيب أو ممرضك إذا كنت تعاني أو عانيت مسبقاً من هذه الحالات المرضية:</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فشل تنفّسي (داء الرئة) (قد تحتاج إلى مراقبة تحديداً في هذه الحالات المذكورة)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->أيّ نوعٍ من أمراض القلب أو ضعف في وظيفة القلب</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ضعف في وظيفة الكليتين</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ارتفاع في ضغط الدم</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->احتباس السوائل تحت الجلد ، وتحديداً عند منطقة الكاحلين (وذمة محيطية)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->احتباس السوائل في الرئتين (وذمة رئوية)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ارتفاع ضغط الدم أثناء الحمل (مقدمات الارتعاج)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مرض يسبّب مستويات عالية من هرمون يُسمّى الألدوستيرون</p><p dir="RTL" style="margin-left:20.1pt; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->أي حالة أخرى مرتبطة باحتباس الصوديوم (عندما يحتفظ الجسم بالكثير من الصوديوم)، مثل العلاج بالستيرويدات (أنظر قسم &quot;تناول أدوية أخرى مع رينجر&quot; أدناه).</p><p dir="RTL" style="margin-left:0in; margin-right:31.85pt; text-align:right; text-indent:-26.65pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->- إذا كنت تعاني من مشاكل في مستويات السوائل في دماغك (على سبيل المثال ، بسبب التهاب السحايا أو النزيف في الجمجمة أو إصابة الدماغ)<br />- إذا كانت لديك حالة يمكن أن تسبب مستوى عال من فاسوبريسين ، وهو هرمون ينظم السائل في جسمك ، مثل<br />o&nbsp; مرض أو إصابة مفاجئة وخطيرة<br />o أجريت لك عملية جراحية<br />o أمراض الدماغ<br />o تتناول بعض الأدوية.<br />قد تزيد هذه الحالات من خطر انخفاض مستويات الصوديوم في دمك ، مما قد يؤدي إلى الصداع والغثيان والنوبات والخمول والغيبوبة والتورم في الدماغ.<br />الأشخاص الأكثر عرضة لخطر تورم الدماغ هم:<br />o&nbsp; أطفال<br />o&nbsp; النساء (خاصة إذا كنت في سن الخصوبة)</p><p dir="RTL" style="margin-left:0in; margin-right:31.85pt; text-align:right; text-indent:-26.65pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت تعاني من قصور في قشرة الكظر ، حيث لا تفرز الغدد في الجسم ما يكفي من بعض الهرمونات (قصور الغدة الكظرية) (هذا المرض في الغدة الكظرية يؤثر على الهرمونات التي تتحكم في تركيز المواد الكيميائية في الجسم).<br />- فقدان الماء من الجسم (الجفاف الحاد ، مثل القيء أو الإسهال)<br />- تلف الأنسجة واسع النطاق (كما يمكن أن يحدث في الحروق الشديدة)<br />- الأمراض المرتبطة بارتفاع مستويات فيتامين (د) (مثل الساركويد ، وهو مرض يصيب الجلد والأعضاء الداخلية)<br />- الأمراض المرتبطة بحصى الكلى<br />- يجب ألا يخلط سيفترياكسون ، وهو مضاد حيوي ، مع هذا الدواء أو يعطى في نفس الوقت مثل أي محلول يحتوي على الكالسيوم ، عندما يعطى لك من خلال الوريد. هذا الدواء يحتوي على الكالسيوم. إذا كان عمرك أكبر من 28 يومًا ، فقد يتم إعطاؤك عقار سيفترياكسون ومحلول الكالسيوم ، واحد تلو الأخر ، طالما أن طبيبك يتخذ الإجراءات اللازمة لتجنب الأدوية التي تتفاعل مع بعضها البعض. إذا كنت تعاني أنت أو طفلك من انخفاض حجم الدم ، فسيتجنب طبيبك إعطاؤك أنت أو طفلك الكالسيوم والسيفترياكسون بالتتابع<br />- فشل القلب.</p><p dir="RTL" style="margin-right:5.15pt; text-align:right">عندما يتم إعطاؤك هذه الحقنة، سيأخذ الطبيب عينات من الدم والبول ويراقب:</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نسبة السوائل في جسمك</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مؤشراتك الحيوية</p><p dir="RTL" style="margin-left:22.05pt; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كمية المواد الكيميائية مثل الصوديوم، والبوتاسيوم، والكالسيوم والكلوريد في الدم (شوارد البلازما في دم)</p><p dir="RTL" style="margin-right:5.15pt; text-align:right">على الرغم من أن محلول رينجر يحتوي على البوتاسيوم والكالسيوم، إنما النسبة لا تكفي من أجل:</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->المحافظة على مستويات هذه المواد كيميائية</p><p dir="RTL" style="margin-left:10.65pt; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->وعلاج مستويات منخفضة جداً في بلازما الدم من البوتاسيوم (نقص البوتاسيوم الشديد) أو الكالسيوم (نقص الكالسيوم الشديد).</p><p dir="RTL" style="margin-left:3.2pt; margin-right:5.1pt; text-align:right">متى تمّ علاج جفاف الجسم من خلال محلول رينجر، سيعطيك الطبيب حقنة أخرى تزوّدك بالبوتاسيوم والكالسيوم. سيأخذ الطبيب بالاعتبار إذا تمّ منحك غذاءً بالوريد. إذا تم إعطائك محلول رينجر لمدّة طويلة، سيصف لك الطبيب مصدراً غذائياً إضافياً.</p><p dir="RTL" style="margin-left:2.8pt; margin-right:5.1pt; text-align:right">يُمكن لكلوريد الكالسيوم أن يكون مؤذياً إذا تمّ حقنه من خلال أنسجة الجسم. لذلك لا يجب حقن محلول رينجر في العضلات (الحقن في العضل). يتّخذ الطبيب كافة الاحتياطات من أجل تجنّب أي تسريبٍ للمحلول إلى الخلايا المحيطة بالعرق.</p><p dir="RTL" style="margin-right:5.1pt; text-align:right">لا يمكن حقن محلول رينجر بالإبرة نفسها التي تُستخدَم لنقل الدم. يمكن لذلك أن يتلف خلايا الدم الحمراء أو يتسبّب بتكتّلها.</p><p style="text-align:right">تناول <strong>أدوية</strong> أخرى و <strong>محلول رينجر</strong></p><p dir="RTL" style="margin-left:100.2pt; margin-right:5.2pt; text-align:right">يجب إعلام الطبيب أو المُمرّضة إذا كنت تتناول أدوية أخرى، أو سبق أن تناولتها مؤخراً.</p><p dir="RTL" style="margin-left:100.2pt; margin-right:5.2pt; text-align:right">من المهم جداً أن تبلغ الطبيب إذا كنت تتناول:</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->سيفترياكسون (مضاد حيوي)، عندما يتم وصفه لك عن طريق الحقن بالوريد (راجع قسم التحذيرات والاحتياطات)</p><p dir="RTL" style="margin-left:14.1pt; margin-right:22.15pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->غليكوزيدات القلب (مقويات للقلب) مثل الديجيتال أو الديجوكسين، التي تستخدم لعلاج قصور القلب إذ يجب ألا تستخدم مع محلول رينجر (راجع أيضاً قسم &quot;لا تستخدم محلول رينجر إذا كنت تعاني ...&quot;). قد تزيد آثار هذه الأدوية بفعل الكالسيوم، ما قد يؤدي إلى تغييرات تهدّد حياة المريض بسبب تغيّر ضربات القلب</p><p dir="RTL" style="text-align:right">يمكن أن تسبب الأدوية التالية في تخزين الجسم للصوديوم والماء ، مما يؤدي إلى تورم الأنسجة وارتفاع ضغط الدم<br />- الستيرويدات القشرية (الأدوية المضادة للالتهابات) كاربينوكسولون (دواء مضاد للالتهابات يستخدم لعلاج قرحة المعدة)</p><p dir="RTL" style="margin-left:21.55pt; margin-right:5.2pt; text-align:right">يُمكن للأدوية المذكورة تالياً أن تزيد من تركيز البوتاسيوم في الدم، الأمر الذي يشكّل تهديداً على حياة المريض. قد يكون ارتفاع مستويات البوتاسيوم في الدم نتيجة لمرض الكلى.</p><p dir="RTL" style="margin-left:55.75pt; margin-right:22.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مدرّات البول الموفرة للبوتاسيوم (بعض أقراص المياه على مثال الأميلورايد، والسبيرونولاكتون وتريامتيرين) (لاحظ أنّ هذه الأدوية قد تكون مندرجة في تركيبة منتجات طبية)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مثبطات للإنزيم المحول للأنجيوتنسين (تُستخدم لعلاج ارتفاع ضغط الدم)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مضادات مستقبلات الأنجيوتنسين2 (تستخدم لعلاج ارتفاع ضغط الدم)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تاكروليموس (يستخدم لمنع رفض الأعضاء المزروعة وعلاج بعض الأمراض الجلدية)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->السيكلوسبورين (يستخدم لمنع رفض الأعضاء المزروعة)</p><p dir="RTL" style="margin-left:0in; margin-right:31.85pt; text-align:right; text-indent:-26.65pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->بعض الأدوية يمكن أن تزيد من خطر الآثار الجانبية بسبب انخفاض مستويات الصوديوم في الدم. قد تشمل هذه الأدوية:<br />- أقراص الماء (مدرات البول)<br />- أدوية للألم و / أو الالتهاب (المعروف أيضًا باسم مضادات الالتهاب غير الستيروئيدية)<br />- مضادات الذهان<br />- الأدوية المستخدمة لعلاج الاكتئاب (مثبطات امتصاص السيروتونين الانتقائية)<br />- الأدوية التي تنتج تأثيرات تشبه المورفين (المواد الأفيونية)<br />- بعض الأدوية المستخدمة لعلاج الصرع (مضادات الصرع)<br />- هرمون يسمى الأوكسيتوسين (يؤدي إلى تقلص الرحم)<br />- بعض الأدوية المستخدمة لعلاج السرطان (العلاج الكيميائي).<br />- أدوية الكوليسترول<br />- أدوية السكري</p><p dir="RTL" style="margin-right:5.15pt; text-align:right">الأدوية الأخرى التي يمكن أن تؤثر أو تتأثر بمحلول رينجر هي:</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مدرات البول الثيازيدية مثل الهيدروكلوروثَيازيد أو الكلورتاليدون</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فيتامين د</p><p style="text-align:right"><strong>محلول رينجر مع الأكل والشرب</strong></p><p dir="RTL" style="margin-left:0in; margin-right:5.15pt; text-align:right">يُفضّل أن تراجع الطبيب لمعرفة ما الذي يُسمح لك بتناوله أوشربه</p><p style="text-align:right"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL" style="margin-left:21.55pt; margin-right:5.15pt; text-align:right">إذا كنتِ حاملاً أو ترضّعين طبيعياً، أو تعتقدين أنك حامل أو تخططين لتحملي، اطلبي نصيحة الطبيب أو المُمرّضة قبل أن تأخذي هذا الدواء.</p><p dir="RTL" style="margin-right:5.15pt; text-align:right">يُمكن استخدام محلول رينجر بأمان أثناء الحمل أو الرضاعة الطبيعية طالما يتم التحكم&nbsp; و مراقبة&nbsp; توازن السوائل والكهارل (Electrolyte)&nbsp; من قبل طبيبك. سيأخذ طبيبك حذرًا خاصًا إذا كنتِ تتناولين الأوكسيتوسين أثناء المخاض</p><p dir="RTL" style="margin-left:21.55pt; margin-right:5.15pt; text-align:right">يمكن للجنين أن يمتصّ الكالسيوم من خلال المشيمة، ومن خلال الرضاعة الطبيعية بعد الولادة. سيقوم الطبيب بمراقبة مستويات المواد الكيميائية في الدم ومقدار السوائل في جسمك.</p><p dir="RTL" style="margin-right:5.15pt; text-align:right">ومع ذلك، إذا توجّب إضافة دواء آخر إلى المحلول الخاص بك للحقن أثناء الحمل خاصة أثناء المخاض أو الرضاعة الطبيعية، يجدر بك:</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مراجعة الطبيب</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->قراءة نشرة الدواء المُضاف.</p><p style="text-align:right"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL" style="margin-left:0in; margin-right:5.1pt; text-align:right">لا يؤثر محلول رينجر في قدرتك على القيادة أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-right:5.1pt; text-align:right">يعطى من قبل الطبيب أو المُمرّضة ، وسيقرّر الطبيب الكمية التي تحتاج إليها والتوقيت المناسب. يعتمد هذا الأمر على العمر والوزن والحالة، وسبب استخدام رينجر. كما قد تتأثّر كمية المحلول التي تُعطى لك بالعلاجات التي تخضع لها.</p><p>يجب ألّا يتم وصف رينجر لكَ إذا كان هناك جسيمات عائمة في المحلول أو إذا كان الكيس تالفاً بأي شكلٍ من الأشكال.</p><p dir="RTL" style="margin-left:20.9pt; margin-right:5.2pt; text-align:right"><strong>&nbsp;</strong>يتم إعطاء محلول رينجر عبر أنبوب بلاستيكي موصول بإبرة يتم إدخالها في الوريد. عادة ما يُستخدم الوريد في ذراعك عند الحقن. ومع ذلك، قد يستخدم الطبيب طريقة أخرى ليعطيك الدواء.</p><p dir="RTL" style="margin-right:5.2pt; text-align:right">عندما يتم إعطاء رينجر، سيأخذ الطبيب عينات من الدم ليراقب :</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مستويات الصوديوم، والبوتاسيوم، والكالسيوم والكلوريد في الدم</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مستويات السوائل في جسمك</p><p dir="RTL" style="margin-right:5.2pt; text-align:right">يجب التخلّص من كل محلولٍ لم يتم استخدامه. لا يجب استخدام رينجر من كيس سبق أن تمّ استخدامه جزئياً.</p><p>في حال تمّ حقن نسبة من رينجر أعلى من المعدّل الطبيعي</p><p dir="RTL" style="margin-left:0in; margin-right:5.2pt; text-align:right"><strong>&nbsp;</strong>في حال تمّ حقن نسبة من رينجر فائضة عن المعدّل الطبيعي، أو تمّ حقن المحلول بسرعة، قد تظهر الأعراض التالية:</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الماء و/أو الصوديوم (الملح) الزائد مع احتباس السوائل في الأنسجة (وذمة) مما يسبب التورم</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->شعور بالنمل أو بالحكة في الذراعين والساقين (مذَل)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ضعف العضل</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->عدم القدرة على التحرّك</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->عدم انتظام ضربات القلب</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إحصار القلب (ضربات قلب بطيئة جداً)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->سكتة قلبية (توّقف القلب عن العمل؛ حالة تهدد الحياة المريض)</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الارتباك</p><p dir="RTL" style="margin-left:0in; margin-right:22.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فقدان الشهية (فقدان الشهية العصابي)</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->التوعك (الغثيان)</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->القيء</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الإمساك</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->آلام في البطن</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الاضطرابات النفسية مثل التهيج أو الاكتئاب</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->شرب الكثير من الماء (عطش شديد)</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->التبول أكثر من المعتاد (غزارة البول)</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->أمراض الكليتين بسبب تراكم الكالسيوم فيهما (نيفروكالسينوسيس)</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الحصاة الكلوية</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الغيبوبة (فقدان الوعي)</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->طعم معدني في الفم</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الاحمرار (هبات ساخنة)</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->توسع الأوعية الدموية في الجلد (توسع الأوعية المحيطية)</p><p dir="RTL" style="margin-left:0in; margin-right:22.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->انخفاض قلوية الدم، مما يسبّب التعب، والارتباك، والخمول وارتفاع معدّل التنفّس</p><p dir="RTL" style="margin-left:21.55pt; margin-right:5.1pt; text-align:right">إذا تطوّرت لديك أي من هذه الأعراض يجب أن تقوم بإبلاغ الطبيب فوراً. سيتم إيقاف الحقنة ومنحك العلاج وفقاً للأعراض.</p><p dir="RTL" style="margin-right:5.1pt; text-align:right">إذا أضيف دواء إلى رينجر قبل حدوث الحقن الزائد، فإنّ هذا الدواء قد يسبب أعراضاً أخرى. يجب أن تقرأ النشرة المرفقة بالدواء المُضاف حيث تتوفّر لائحة بالأعراض المُحتملة.</p><p>التوقّف عن استخدام محلول رينجر</p><p dir="RTL" style="margin-right:5.15pt; text-align:right"><strong>&nbsp;</strong>يقرّر الطبيب وقت الانتهاء من أخذ رينجر.</p><p dir="RTL" style="margin-right:5.15pt; text-align:right">إذا كانت لديك أيّ أسئلة فلا تتردّد في استشارة الطبيب أو المُمرّضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:89.35pt; margin-right:11.2pt; text-align:right">قد يسبّب رينجر آثاراً جانبية مثل كافة الأدوية، مع العلم أنّها لا تظهر لدى جميع الأشخاص.</p><p dir="RTL" style="margin-left:89.35pt; margin-right:11.2pt; text-align:right">تمّ تدوين حالات الآثار الجانبية وفقاً لتكرار حدوثها.</p><p dir="RTL" style="margin-left:0in; margin-right:11.2pt; text-align:right"><strong>الآثار الجانبية الشائعة جداً </strong>(تصيب أكثر من 1 لكل 10 مرضى)</p><p dir="RTL" style="margin-left:96.7pt; margin-right:11.2pt; text-align:right; text-indent:0in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تغيرات في تركيزات المواد الكيميائية في الدم (اضطرابات الشوارد) إذا كنت تعاني أمراض القلب أو احتباس السوائل في الرئتين (وذمة رئوية):</p><p dir="RTL" style="margin-left:0in; margin-right:28.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->احتباس كبير للسوائل في الجسم (فرط التميّه)</p><p dir="RTL" style="margin-left:0in; margin-right:28.1pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نوبة قلبية</p><p>آثار جانبية أخرى</p><p dir="RTL" style="margin-left:0in; margin-right:28.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ردّات فعل ناجمة عن تقنية إعطاء الدواء:</p><p dir="RTL" style="margin-left:0in; margin-right:44.55pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الحمى (استجابة حموية)</p><p dir="RTL" style="margin-left:0in; margin-right:44.55pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->انتقال عدوى عند الحقن</p><p dir="RTL" style="margin-left:0in; margin-right:44.55pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ألم موضعي أو ردّ فعل (احمرار أو تورم في موقع الحقن)</p><p dir="RTL" style="margin-left:21.55pt; margin-right:44.55pt; text-align:right; text-indent:-16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تهيّج والتهاب الوريد الذي تمّ حقن المحلول فيه (التهاب وريدي)، ممّا يسبب احمراراً، أو ألماً أو حرقاً وتورماً على طول العرق.</p><p dir="RTL" style="margin-left:15.35pt; margin-right:44.55pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تشكّل جلطة دموية (تخثر وريدي) في موقع الحقنة، مما يسبب الألم، أو التورم أو الاحمرار في منطقة الجلطة</p><p dir="RTL" style="margin-left:18.45pt; margin-right:44.55pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تسرّب المحلول إلى الأنسجة حول الوريد، هذا يضرّ الأنسجة وقد يسبب ندبة.</p><p dir="RTL" style="margin-left:0in; margin-right:28.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->انخفاض مستويات الصوديوم في الدم (نقص صوديوم الدم(</p><p dir="RTL" style="margin-left:0in; margin-right:28.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تورم في المخ مما قد يؤدي إلى إصابة الدماغ (الوذمة الدماغية(</p><p dir="RTL" style="margin-left:5.5pt; margin-right:11.15pt; text-align:right">إذا تمت إضافة دواء إلى محلول الحقن، قد يسبب الدواء المُضاف أيضاً آثاراً جانبية. تعتمد الآثار الجانبية هذه على الدواء الذي تمت إضافته. ينبغي أن تقرأ النشرة المرفقة بالدواء المُضاف حيث تتوفر قائمة بالأعراض المحتملة.</p><p dir="RTL" style="margin-left:9.45pt; margin-right:11.15pt; text-align:right">أعلِم الطبيب أو المُمرّضة في حال عانيت آثاراً جانبية، حتى لو لم تكن مذكورة ضمن هذه النشرة.</p><p>الإبلاغ عن آثار جانبية</p><p dir="RTL" style="margin-left:5.4pt; margin-right:11.15pt; text-align:justify">إذا لاحظت أي أثارٍ جانبية، تحدّث إلى الطبيب أو الممرّض. يشمل ذلك أيّ آثار جانبية محتملة غير مندرجة ضمن هذه النشرة. يمكنك أيضاً الإبلاغ عن الآثار الجانبية مباشرة عن طريق النظام الوطني للإبلاغ المذكور أدناه.</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:467.5pt"><p dir="RTL" style="margin-left:0in; margin-right:39.05pt; text-align:right; text-indent:-10.3pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->المملكة العربية السعودية:</p><p dir="RTL" style="margin-left:0in; margin-right:39.05pt; text-align:right; text-indent:0in">- المركز الوطني للتيقظ والسلامة الدوائية</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فاكس: 7662-205-11-966+</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->للاتصال بالمركز الوطني للتيقظ والسلامة الدوائية: 2038222 11 966+، الأرقام الداخلية: 2317 - 2356 - 2353 - 2354 - 2334 - 2340.</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الرقم المجاني: 8002490000</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الموقع: www.sfda.gov.sa/npc</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right; text-indent:0in">&nbsp;</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right; text-indent:0in">&Yuml;دول مجلس التعاون الخليجي الأخرى:</p><p dir="RTL" style="margin-left:0in; margin-right:34.05pt; text-align:right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -يُرجى التواصل مع السلطة المختصة ذات الصلة.</p><p>&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:70.9pt; margin-right:10.2pt; text-align:justify">يُحفظ هذا الدواء بعيداً عن متناول لأطفال.</p><p dir="RTL" style="margin-left:229.5pt; margin-right:10.2pt; text-align:right">يحفظ في&nbsp; درجة حرارة لا تزيد عن 30 درجة مئوية.</p><p dir="RTL" style="margin-left:4.65pt; margin-right:10.2pt; text-align:justify; text-indent:3.8pt">لا تستخدم هذا الدواء بعد انتهاء تاريخ الصلاحية المطبوع على الكيس. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p dir="RTL" style="margin-left:0in; margin-right:36.8pt; text-align:justify; text-indent:-27.3pt">لا يجدر بك أخذ هذا الدواء إذا كان هناك جسيمات عائمة في المحلول أو إذا كان الكيس تالفاً بأي شكلٍ</p><p dir="RTL" style="margin-left:0in; margin-right:10.2pt; text-align:justify">من الأشكال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:0in; margin-right:10.2pt; text-align:right">المواد الفعّالة:</p><p dir="RTL" style="margin-left:0in; margin-right:10.2pt; text-align:right; text-indent:16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كلوريد الصوديوم: 8.60 غ في الليتر الواحد</p><p dir="RTL" style="margin-left:0in; margin-right:10.2pt; text-align:right; text-indent:16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كلوريد البوتاسيوم: 0.30 غ في الليتر الواحد</p><p dir="RTL" style="margin-left:244.95pt; margin-right:10.2pt; text-align:right; text-indent:16.9pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كلوريد الكالسيوم ثنائي الهيدرات: 0.33 غ لكل لتر المكونات الأخرى هي:</p><p dir="RTL" style="margin-left:0in; margin-right:44.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ماء للحقن</p><p dir="RTL" style="margin-left:0in; margin-right:44.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->هدروكسيد الصوديوم</p><p dir="RTL" style="margin-left:0in; margin-right:44.05pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->حَمض الهيدروكلوريك</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:0in; margin-right:10.15pt; text-align:right">محلول رينجر هو محلولٌ نقيّ، خالٍ من أيّ جسيمات مرئية.</p><p dir="RTL" style="text-align:right">يتم توفيره في أكياس بلاستيكية من البولي أوليفين / البولياميد (Viaflex). يتم لف كل كيس بغطاء بلاستيكي خارجي محكم وقائي.</p><p dir="RTL" style="margin-right:10.15pt; text-align:right">أحجام الأكياس تسع لـ:</p><p dir="RTL" style="margin-left:0in; margin-right:10.15pt; text-align:right">-&nbsp;&nbsp;&nbsp; 500 مل</p><p dir="RTL" style="margin-left:0in; margin-right:10.15pt; text-align:right">-&nbsp;&nbsp;&nbsp; 1000 مل</p><p dir="RTL" style="margin-right:10.15pt; text-align:right">الأكياس متوفّرة في علب من الكرتون. وتحتوي كلّ علبة كرتون على الكميّات التالية:</p><p dir="RTL" style="margin-left:0in; margin-right:27.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->26 كيساً حجم 500 مل</p><p dir="RTL" style="margin-left:0in; margin-right:27.1pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->16 كيساً حجم 1000 مل</p><p dir="RTL" style="text-align:right">قد لا يتم تسويق جميع أحجام العبوات</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:311.4pt; margin-right:10.15pt; text-align:right"><strong>الشركة الحائزة على ترخيص للتسويق:</strong> شركة باكستر المحدودة</p><p dir="RTL" style="margin-left:313.4pt; margin-right:5.2pt; text-align:right">المنطقة الصناعية الثانية طريق رقم 2041 الدمام، المملكة العربية السعودية</p><p dir="RTL" style="margin-left:0in; margin-right:10.15pt; text-align:right"><strong>الشركة المصنّعة:</strong></p><p dir="RTL" style="margin-right:10.15pt; text-align:right">شركة باكستر المحدودة</p><p dir="RTL" style="margin-left:313.4pt; margin-right:5.2pt; text-align:right">المنطقة الصناعية الثانية طريق رقم 2041 الدمام، المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            11/2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ringer’s Solution for Infusion

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sodium chloride:                            8.60 g/l
Potassium chloride:                       0.30 g/l
Calcium chloride dihydrate:         0.33 g/l
mmol/l:                         Na+ : 147               K+ : 4                       Ca++ : 2.25                              Cl-:155.5
mEq/l:                           Na+ : 147              K+ : 4                        Ca++ : 4.5                                 Cl-:155.5
For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
Clear solution, free from visible particles.
Osmolarity: 309 mOsm/l (approx)
pH: 5.0 to 7.5

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ringer&rsquo;s Solution for Infusion is indicated to:<br />- Replace extracellular fluid losses,<br />- Restore the sodium, potassium, calcium and chloride balances, for treatment of isotonic dehydration</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u><br /><em>Adults, the Elderly, Adolescents and Children:</em><br />Fluid balance, serum electrolytes and acid-base balance may need to be monitored before and during administration, with particular attention to serum sodium in patients with increased nonosmotic<br />vasopressin release (syndrome of inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medicated with vasopressin agonist drugs, due to the risk of hospital acquired<br />hyponatraemia (see sections 4.4, 4.5 and 4.8). Monitoring of serum sodium is particularly important for hypotonic fluids.<br />Ringer&rsquo;s Solution tonicity: Isotonic solution<br />The infusion rate and volume depend on the age, weight, clinical condition (e.g. burns, surgery, head-injury, infections), and concomitant therapy should be determined by the consulting physician experienced in<br />paediatric intravenous fluid therapy (see sections 4.4. and 4.8).<br /><em>Recommended dosage:</em><br />The recommended dosage is:<br />- for adults, the elderly and adolescents : 500 ml to 3 liters /24h<br />- for babies and children : 20 ml to 100 ml / kg / 24 h</p><p><em>Administration rate:</em><br />The infusion rate is usually 40 ml/kg/24h in adults, the elderly and adolescents.<br />In paediatric patients the infusion rate is 5 ml/kg/h in average but the value varies with age: 6-8 ml/kg/h for infants, 4-6 ml/kg/h for toddlers, and 2-4 ml/kg/h for schoolchildren. In children with burns, the dose is on<br />average 3.4 ml/kg/per cent burn at 24 h post-burn and 6.3 ml/kg/per cent burn at 48 h</p><p>In severely head-injured children the dose is on average 2850 ml/m&sup2;.<br />Infusion rate and total volume can be higher in surgery or in case of need.<br />Note:<br />- Infants and toddlers: aged from 28 days to 23 months (a toddler is an infant who can walk)<br />- Children and schoolchildren: aged from 2 years to 11 years<br /><em>Method of administration:</em><br />The administration is performed by intravenous route.<br />The solution for infusion should be visually inspected prior to use.<br />Use only if the solution is clear, without visible particles and if the container is undamaged. Administer immediately following the insertion of infusion set. Do not remove unit from overwrap until ready for<br />use.The inner bag maintains the sterility of the product.<br />Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before the administration of the fluid from the secondary container<br />is completed.<br />Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in air embolism if the residual air in the container is not fully evacuated prior to administration.<br />Use of a vented intravenous administration set with the vent in the open position could result in air<br />embolism. Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers.<br />The solution should be administered with sterile equipment using an aseptic technique. The equipment should be primed with the solution in order to prevent air entering the system.<br />Additives may be introduced before infusion or during infusion through the injection site</p><p><em>Monitoring</em><br />Fluid balance and plasma electrolytes concentrations (sodium, potassium, calcium and chlorides) must be monitored during administration</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The solution is contraindicated in patients presenting with:
- Extracellular hyperhydration or hypervolemia
- Hypertonic dehydration
- Hyperkalemia
- Hypernatremia
- Hypercalcaemia
- Hyperchloraemia
- Severe renal insufficiency (with oliguria/anuria)
- Uncompensated cardiac failure
- Severe hypertension
- General oedema and ascitic cirrhosis
- Concomitant digitalis therapy (see section 4.5)
As for other calcium-containing infusion solutions , treatment with ceftriaxone and Ringer's Solution for Infusion is contraindicated in preterm newborn infants and term newborn infants (≤28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxone calcium salt precipitation in the neonate’s bloodstream)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ringer&rsquo;s Solution for Infusion contains insufficient concentration of potassium and calcium to be used for maintenance of these ions or to correct their deficits. Hence, after dehydration is treated, the IV fluid has to<br />be changed to a maintenance fluid that will provide these ions.<br />During long-term parenteral treatment, a convenient nutritive supply must be given to the patient.</p><p>Depending on the volume and rate of infusion, intravenous administration of Ringer&rsquo;s Solution can cause fluid retention and or/solute overload resulting in overhydration and for example, congested states, including<br />pulmonary congestion and edema.<br />Solutions containing sodium chloride should be administered with caution to patients with hypertension, heart failure, peripheral or pulmonary oedema, impaired renal function, pre-eclampsia, aldosteronism or<br />other conditions or treatment (e.g. corticoids/steroids) associated with sodium retention (see also Section 4.5<br />&ndash; Interactions with other medicinal products and other forms of interaction).<br />Solutions containing potassium salts should be administered with caution to patients with cardiac disease, or conditions predisposing to hyperkalemia such as renal or adrenocortical insufficiency, acute dehydration, or<br />extensive tissue destruction as occurs with severe burns.<br />Clinical evaluation and periodic laboratory determinations may be necessary to monitor changes in fluid balance, electrolyte concentrations, and acid&ndash;base balance during prolonged parenteral therapy or whenever<br />the condition of the patient or the rate of administration warrants such evaluation.<br />High volume infusion must be used under specific monitoring in patients with cardiac or pulmonary failure, and in patients with non-osmotic vasopressin release (including SIADH), due to the risk of<br />hospital-acquired hyponatraemia (see below)</p><p>Hyponatraemia<br />Patients with non-osmotic vasopressin release (e.g. in acute illness, pain, post-operative stress, infections, burns, and CNS diseases), patients with heart-, liver- and kidney diseases and patients<br />exposed to vasopressin agonists (see section 4.5) are at particular risk of acute hyponatraemia upon infusion of hypotonic fluids.<br />Acute hyponatraemia can lead to acute hyponatraemic encephalopathy (cerebral oedema) characterized by headache, nausea, seizures, lethargy and vomiting. Patients with cerebral oedema<br />are at particular risk of severe, irreversible and life-threatening brain injury.<br />Children, women in the fertile age and patients with reduced cerebral compliance (e.g. meningitis, intracranial bleeding, cerebral contusion and brain oedema) are at particular risk of the severe and<br />life-threatening brain swelling caused by acute hyponatraemia.</p><p>Because of the presence of calcium:<br />- care should be taken to prevent extravasation during intravenous infusion<br />- the solution should be given cautiously to patients with impaired renal function or calcium renal calculi or a history of such calculi or diseases associated with elevated vitamin D concentrations<br />such as sarcoidosis<br />- in case of concomitant blood transfusion, the solution must not be administered via the same infusion set because of the risk of coagulation.<br /><em>Calcium-Ceftriaxone precipitates</em><br />Cases of fatal reactions with calcium-ceftriaxone precipitates in lungs and kidneys in premature and full-term newborn infants aged less than 1 month have been described.<br />In patients of any age ceftriaxone must not be mixed or administered simultaneously with any calciumcontaining IV solutions even via different infusion lines or different infusion sites<br />However, in patients older than 28 days of age ceftriaxone and calcium-containing solutions may be administered sequentially one after another if infusion lines at different sites are used or if the infusion lines<br />are replaced or thoroughly flushed between infusions with physiological salt-solution to avoid precipitation.<br />Sequential infusions of ceftriaxone and calcium-containing products must be avoided in case of hypovolaemia</p><p><em>Renal function</em><br />Ringer&rsquo;s Solution should be administered with particular caution, to patients with or risk of severe renal impairment. In such patients, administration of Ringer&rsquo;s solution may result in electrolyte abnormalities.<br />For information on preparation of the product and additives, please see section 6.6.<br /><em>Pediatric use</em><br />Plasma electrolyte concentrations should be closely monitored in the pediatric population.<br /><em>Elderly</em><br />When selecting the type of infusion solution and the volume/rate of infusion for a elderly patient, consider that elderlypatients are generally more likely to have cardiac, renal, hepatic, and/or other diseases, and/or<br />concomitant drug therapy.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Interaction with ceftriaxone</em><br />- Concomitant treatment with ceftriaxone and Ringer&#39;s Solution for Infusion is contraindicated in preterm newborn infants and term newborn infants (&le;28 days of age), even if separate infusion lines<br />are used (risk of fatal ceftriaxone-calcium salt precipitation in the neonate&rsquo;s bloodstream) (see Section 4.3).<br />- In patients older than 28 days (including adults), ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions, including Ringer&#39;s Solution for Infusion (See Section<br />4.4) or via different infusion lines or different infusion sites (see section 6.2).<br /><em>Interaction related to the presence of sodium:</em><br />- Corticoids/Steroids and carbenoxolone, which are associated with the retention of sodium and water (with oedema and hypertension).<br /><em>Interaction related to the presence of potassium:</em><br />- Potassium-sparing diuretics (amiloride, spironolactone, triamterene, alone or in association),<br />- Angiotensin converting enzyme inhibitors (ACEI) and, by extrapolation, angiotensin II receptor antagonists,<br />- Tacrolimus, cyclosporine,which increase concentration of potassium in the plasma and may lead to potentially fatal hyperkalemia notably in case of a renal failure increasing the hyperkalemic effect</p><p><em>Interaction related to the presence of calcium:</em><br />- Digitalis glycosides (digitalis cardiotonics) whose effects are enhanced by the presence of calcium and may lead to serious or fatal cardiac arrhythmia (see section 4.3).<br />- Thiazide diuretics or vitamin D which can lead to hypercalcemia when co-administered with calcium.</p><p><br />Drugs leading to an increased vasopressin effect.<br />The below listed drugs increase the vasopressin effect, leading to reduced renal electrolyte free water excretion and may increase the risk of hospital acquired hyponatraemia following inappropriately balanced<br />treatment with i.v. fluids (see sections 4.2, 4.4 and 4.8).<br />- Drugs stimulating vasopressin release include: Chlorpropamide, clofibrate, carbamazepine, vincristine, selective serotonin reuptake inhibitors, 3.4-methylenedioxy-N-methamphetamine, ifosfamide,<br />antipsychotics, narcotics<br />- Drugs potentiating vasopressin action include: Chlorpropamide, NSAIDs, cyclophosphamide<br />- Vasopressin analogues include: Desmopressin, oxytocin, vasopressin, terlipressin<br />Other medicinal products increasing the risk of hyponatraemia also include diuretics in general and antiepileptics such as oxcarbazepine.</p><p>For information on incompatibilities between this and other products, please see section 6.2.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Ringer&rsquo;s solution for infusion can be used safely during pregnancy and lactation as long as the electrolyte and fluid balance is controlled.<br />When a medicinal product is added, the nature of the drug and its use during pregnancy and lactation have to be considered separately.<br />Ringer&rsquo;s Solution should be administrated with special caution for pregnant women during labour particularly as to serum-sodium if administered in combination with oxytocin (see section 4.4, 4.5 and 4.8)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no information on the effect of Ringer&rsquo;s Solution on the ability to operate an automobile or other heavy machinery.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions have been reported in the post-marketing experience, listed by MedDRA System Organ Class (SOC), then by Preferred Term in order of severity, where feasible.</p><p style="text-align:center">Tabulated list of adverse reactions</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:155.8pt"><p><strong>MedDRA System</strong></p><p><strong>Organ Class</strong></p></td><td style="vertical-align:top; width:155.85pt"><p><strong>Adverse Reactions</strong></p><p><strong><em>(Preferred term)</em></strong></p></td><td style="vertical-align:top; width:155.85pt"><p><strong>Frequency</strong></p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:155.8pt"><p>Metabolism and</p><p>nutrition disorders</p><p>&nbsp;</p></td><td style="vertical-align:top; width:155.85pt"><p>Hyperhydration*</p><p style="margin-left:0in; margin-right:0in">Electrolytes disturbances</p><p style="margin-left:0in; margin-right:0in">Hospital acquired hyponatraemia**</p><p>&nbsp;</p></td><td style="vertical-align:top; width:155.85pt"><p>Very common</p><p style="margin-left:0in; margin-right:0in">Very common</p><p style="margin-left:0in; margin-right:0in">Not known</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:155.8pt"><p>Cardiac disorders</p></td><td style="vertical-align:top; width:155.85pt"><p>Heart failure*</p></td><td style="vertical-align:top; width:155.85pt"><p>Very common</p><p style="text-align:center">&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:155.8pt"><p>Nervous system</p><p>Disorders</p><p style="text-align:center">&nbsp;</p></td><td style="vertical-align:top; width:155.85pt"><p style="text-indent:.5in">Acute hyponatraemic encephalopathy**</p></td><td style="vertical-align:top; width:155.85pt"><p>Not known</p><p>&nbsp;</p></td></tr></tbody></table><p><em>* in patients with cardiac disorder or pulmonary oedema</em></p><p><em>**Hospital acquired hyponatraemia may cause irreversible brain injury and death due to development of </em><em>&nbsp;</em><em>cute</em></p><p><em>hyponatraemic encephalopathy</em></p><p>&nbsp;</p><p>Fluid overload, hypersensitivity and urticaria have been reported with other similar solutions.</p><p style="margin-left:0in; margin-right:0in">Adverse reactions may be associated to the technique of administration including febrile response, infection</p><p>at the site of injection, local pain or reaction, vein irritation, venous thrombosis or phlebitis extending from</p><p>the site of injection and extravasation.</p><p>Adverse reactions may be associated to the medicinal product added to the solution; the nature of the</p><p>additive will determine the likelihood of any other adverse reactions.</p><p>In case of adverse reaction(s), the infusion must be discontinued.</p><p style="margin-left:0in; margin-right:0in">Reporting of suspected adverse reactions</p><p><em>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It</em></p><p><em>allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare</em></p><p><em>professionals are asked to report any suspected adverse reactions via.</em></p><p>&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:467.5pt"><p>&bull; Saudi Arabia:</p><p>&nbsp;</p><p>The&nbsp;National&nbsp;Pharmacovigilance&nbsp;and&nbsp;Drug&nbsp;Safety&nbsp;Centre&nbsp;(NPC)&nbsp;&nbsp;</p><p>&bull;&nbsp;Fax:&nbsp;+966‐11‐205‐7662&nbsp;&nbsp;</p><p>&bull;&nbsp;Call&nbsp;NPC&nbsp;at&nbsp;+966‐11‐2038222,&nbsp;Exts:&nbsp;2317‐2356‐‐2340.&nbsp;&nbsp;</p><p>&bull;&nbsp;Toll&nbsp;free&nbsp;phone:&nbsp;19999&nbsp;</p><p style="margin-left:0in; margin-right:0in">&bull;&nbsp;E‐mail:&nbsp;&nbsp;npc.drug@sfda.gov.sa&nbsp;</p><p>&bull;&nbsp;Website:&nbsp;www.sfda.gov.sa/npc</p><p>&bull; Other GCC States:</p><p>&nbsp;Please&nbsp;contact&nbsp;the&nbsp;relevant&nbsp;competent&nbsp;authority.</p><p>&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdose or too fast administration may lead to water and sodium overload with a risk of oedema, particularly when there is a defective renal sodium excretion. In this case extra renal dialysis may be necessary.<br />Excessive administration of potassium may lead to the development of hyperkalemia, especially in patients with renal impairment. Symptoms include paresthesia of the extremities, muscle weakness, paralysis, cardiac<br />arrhythmias, heart block, cardiac arrest, and mental confusion.<br />Treatment of hyperkalemia involves the administration of calcium, insulin (with glucose), sodium bicarbonate, exchange resins or dialysis.<br />Excessive administration of calcium salts may lead to hypercalcemia. Symptoms of hypercalcemia may include anorexia, nausea, vomiting, constipation, abdominal pain, muscle weakness, mental disturbances,<br />polydipsia, polyuria, nephrocalcinosis, renal calculi, and, in severe cases, cardiac arrhythmias and coma. Too rapid intravenous injection of calcium salts may also lead to many of the symptoms of hypercalcemia as well<br />as to chalky taste, hot flushes, and peripheral vasodilatation. Mild asymptomatic hypercalcemia will usually resolve on stopping administration of calcium and other contributory drugs such as vitamin D. If<br />hypercalcemia is severe, urgent treatment (such as loop diuretics, hemodialysis, calcitonin, bisphosphonates, trisodium edetate) is required.</p><p>Excessive administration of chloride salts may cause hyperchloremia and a loss of bicarbonate with an acidifying effect.<br />The effects of an overdose may require immediate medical attention and treatment. Interventions include discontinuation of Ringer&rsquo;s Solution administration, dose reduction, and other measures as indicated for the<br />specific clinical constellation.<br />When overdose is related to medicinal products added to the solution infused, the signs and symptoms of over infusion will be related to the nature of the additive being used.<br />In the event of accidental over infusion, treatment should be discontinued and the patient should be observed for the appropriate signs and symptoms related to the drug administered. The relevant symptomatic and<br />supportive measures should be provided as necessary</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: &ldquo; Electrolytes&rdquo;, ATC code: &quot;B05BB01&rdquo;<br />Ringer&rsquo;s Solution for Infusion is an isotonic solution of electrolytes. The constituents of Ringer&rsquo;s Solution for Infusion and their concentrations are designed to match those of plasma.<br />The pharmacodynamic properties of this solution are those of its components (water, sodium, potassium, calcium, and chloride). The main effect of Ringer&rsquo;s Solution for Infusion is the expansion of the extracellular<br />compartment including both the interstitial and intravascular fluids.<br />Ions, such as sodium, circulate through the cell membrane using various mechanisms of transport among which is the sodium pump (Na+ /K+ -ATPase). Sodium plays an important role in neurotransmission and<br />cardiac electrophysiology, and also in its renal metabolism.<br />Potassium is essential for numerous metabolic and physiological processes including nerve conduction, muscle contraction, and acid-base regulation. A normal concentration of potassium in plasma is about 3.5 to</p><p>5.0 mmoles per liter. Potassium is predominantly an intracellular cation, primarily found in muscle; only about 2% is present in the extracellular fluid. The passage of potassium into the cells and retention against<br />the concentration gradient requires active transport via the Na+ /K+ -ATPase enzyme.<br />Approximately 99% of calcium is incorporated into the skeleton. The remaining 1% is found in body tissues and fluids, and is essential for normal nerve conduction, muscle activity, and blood coagulation.<br />Chloride is mainly an extracellular anion found in low concentration in bone and in high concentration in some components of connective tissue such as collagen. Intracellular chloride is in high concentration in red<br />blood cells and gastric mucosa. The balance of anions and cations is regulated by the kidneys. Reabsorption of chloride generally follows reabsorption of sodium.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetic properties of this solution are those of its components (sodium chloride, potassium chloride, and calcium chloride).<br />The volume and the ionic composition of the extracellular and the intracellular compartments are as follows:<br />Extracellular fluid: approximately 19 liters<br />Sodium (mmol/l):&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 142<br />Potassium (mmol/l):&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5<br />Calcium (mmol/l): &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; 2.5<br />Chloride (mmol/l):&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 103<br />Intracellular fluid: approximately 23 liters<br />Sodium (mmol/l):&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15<br />Potassium (mmol/l): &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; 150<br />Calcium (mmol/l):&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1<br />Chloride (mmol/l):&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1<br />After injection of radiosodium (&nbsp; 24 Na), the half-life is 11 to 13 days for 99% of the injected Na and one year for the remaining 1%. The distribution varies according to tissues: it is fast in muscles, liver, kidney,<br />cartilage and skin; it is slow in erythrocytes and neurones; it is very slow in the bone. Sodium is predominantly excreted by the kidney, but there is extensive renal reabsorption. Small amounts of sodium<br />are lost in the feces and sweat.<br />Factors influencing potassium transfer between intracellular and extracellular fluid such as acid-base disturbances can distort the relationship between plasma concentrations and total body stores. Potassium is<br />excreted mainly by the kidneys; it is secreted in the distal tubules in exchange of sodium or hydrogen ions. The capacity of the kidneys to conserve potassium is poor and some urinary excretion of potassium<br />continues even when there is severe depletion. Some potassium is excreted in the feces and small amounts may also be excreted in sweat.<br />The concentration of calcium in plasma is regulated by parathyroid hormone, calcitonin, and vitamin D.<br />About 47% of calcium in plasma is in the ionized physiologically active form, about 6% is complexed with anions such as phosphate or citrate, and the remainder is bound to proteins, principally albumin. If the<br />plasma-albumin concentration is raised (as in dehydration) or reduced (as is common in malignancy) it will affect the proportion of ionized calcium. Thus, the total plasma-calcium concentration is commonly adjusted<br />for plasma albumin. Excess of calcium is predominantly excreted renally. Unabsorbed calcium is eliminated in the feces, together with that secreted in the bile and pancreatic juice. Minor amounts are lost in the sweat,<br />skin, hair, and nails. Calcium crosses the placenta and is distributed into breast milk.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical safety data of Ringer&rsquo;s solution for infusion in animals are not relevant since its constituents are physiological components of animal and human plasma.<br />Toxic effects are not to be expected under the condition of clinical application.<br />The safety of potential additives should be considered separately.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Water for Injections.</p><p>Sodium hydroxide and Hydrochloric Acid (for pH-adjustment)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Incompatibility of the medicinal product to be added with the solution in Viaflex container must be assessed before addition.<br />Ceftriaxone: See sections 4.3 and 4.4 for more information<br />In the absence of compatibility studies, this solution must not be mixed with other medicinal products.<br />The Instructions for Use of the medicinal product to be added must be consulted. Before adding a drug,<br />verify it is soluble and stable in water at the pH of Ringer&rsquo;s Solution for Infusion (see section 3).<br />Calcium salts have been reported to be incompatible with a wide range of drugs. Complexes may form<br />resulting in the formation of a precipitate.<br />As a guidance, the following medications are incompatible with the Ringer&rsquo;s Solution (non-exhaustive listing):<br />Amphotericin B<br />Cortisone<br />Erythromycin lactobionate<br />Etamivan<br />Ethyl alcohol<br />Thiopental sodium<br />Disodium edetate<br />Those additives known to be incompatible should not be used</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened: 500 ml: 24 months
                     1000 ml: 24 months
In-use shelf life:
Chemical and physical stability of any additive at the pH of the Ringer’s solution in the Viaflex container
should be established prior to use.
From a microbiological point of view, the product should be used immediately. If not used immediately, inuse
storage times and conditions prior to use are the responsibility of the user and would normally not be
longer than 24 hours at 2 to 8°C, unless reconstitution has taken place in controlled and validated aseptic
conditions.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The bags are composed of polyolefin/polyamide co-extruded plastic (PL 2442). The bags are overwrapped<br />with a protective plastic pouch composed of polyamide/polypropylene, which serves only to provide<br />physical protection to the bags.<br />The bag size is either 500 or 1000 ml.<br />Outer carton contents: 26 bags of 500 ml or 16 bags of 1000 ml.<br />Not all pack sizes may be marketed.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Discard after single use.<br />Discard any unused portion.<br />Do not reconnect partially used bags.<br /><u>Opening</u><br />Remove the Viaflex container from the overpouch just before use</p><p>Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution, as sterility may be impaired<br />Check solution for limpidity and absence of foreign matter. If solution is not clear or contains foreign matter, discard the solution.</p><p><u>Preparation for administration</u><br />Use sterile material for preparation and administration.<br />Suspend container from eyelet support.<br />Remove plastic protector from outlet port at bottom of container:<br />&nbsp;&nbsp;&nbsp; o grip the small wing on the neck of the port with one hand<br />&nbsp;&nbsp;&nbsp; o grip the large wing on the cap with the other hand and twist,<br />&nbsp;&nbsp;&nbsp; o the cap will pop off.<br />Use an aseptic method to set up the infusion.<br />Attach administration set. Refer to directions of the accompanying set for connection, priming of the set and administration of the solution.</p><p><u>Techniques for injection of additive medications</u><br />Warning: Additives may be incompatible.<br />When additive is used, verify isotonicity prior to parenteral administration. Thorough and careful aseptic mixing of any additive is mandatory. Solutions containing additives should be used immediately and not stored.<br /><em>To add medication before administration</em><br />Disinfect medication site.<br />Using syringe with 19 to 22 gauge needle, puncture re-sealable medication port and inject.<br />Mix solution and medication thoroughly. For high-density medication such as potassium chloride, tap the ports gently while ports are upright and mix.</p><p><br />Caution: Do not store bags containing added medications.</p><p><em>To add medication during administration</em><br />&nbsp;&nbsp;&nbsp;&nbsp; Close clamp on the set<br />&nbsp;&nbsp;&nbsp;&nbsp; Disinfect medication site.<br />&nbsp;&nbsp;&nbsp;&nbsp; Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.<br />&nbsp;&nbsp;&nbsp;&nbsp; Remove container from IV pole and/or turn to an upright position.<br />&nbsp;&nbsp;&nbsp;&nbsp; Evacuate both ports by tapping gently while the container is in an upright position.<br />&nbsp;&nbsp;&nbsp;&nbsp; Mix solution and medication thoroughly.<br />&nbsp;&nbsp;&nbsp;&nbsp; Return container to in use position, re-open the clamp and continue administration</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Company Limited
2nd Industrial City, Dammam 34334,
Saudi Arabia

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                11/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>